Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

Documentation is especially important for nurse practitioners in cancer research and can lead to improved patient recruitment ...

Autologous stem cell transplant is an advanced treatment method that rapidly restores the patient's hematopoietic system ...

Biomarker testing also extends beyond cancer care. The science is being used in the treatment of other diseases including ...

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

Regarding myeloma, Burke also shares his experience with myeloma BsAbs, saying, “I follow the drug label, administer the drug in the clinic, but then admit the patient directly to the hospital for ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...